CONTINUOUS INFUSION OF HIGH-DOSE METOCLOPRAMIDE FOR THE PREVENTION OF NAUSEA AND VOMITING IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY

被引：19

作者：

JOSS, RA ^{[1
]}

GALEAZZI, RL ^{[1
]}

BRUNNER, KW ^{[1
]}

机构：

[1] UNIV BERN,INSELSPITAL,DEPT INTERNAL MED,CH-3010 BERN,SWITZERLAND

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1983年 / 25卷 / 01期

关键词：

D O I：

10.1007/BF00544011

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：35 / 39

页数：5

共 17 条

[1]

AAPRO MS, 1981, CANCER CHEMOTH PHARM, V7, P11

[2]

BLOCK W, 1981, ARZNEIMITTEL-FORSCH, V31-1, P1041

[3]

BUI NB, 1982, CANCER TREAT REP, V66, P2107

[4]

GOSLIN RH, 1981, TREATMENT CANCER CHE, P159

[5]

GRAFFNER C, 1969, BRIT J CLIN PHARM, V8, P459

[6] ANTI-EMETIC EFFICACY OF HIGH-DOSE METOCLOPRAMIDE - RANDOMIZED TRIALS WITH PLACEBO AND PROCHLORPERAZINE IN PATIENTS WITH CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING [J].

GRALLA, RJ ;

ITRI, LM ;

PISKO, SE ;

SQUILLANTE, AE ;

KELSEN, DP ;

BRAUN, DW ;

BORDIN, LA ;

BRAUN, TJ ;

YOUNG, CW .

NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (16) :905-909

[7]

GRALLA RJ, 1981, TREATMENT CANCER CHE, P167

[8]

JOSS R, 1983, SCHWEIZ MED WSCHR, V113, P426

[9]

JOSS R, 1981, 1981 UICC C CLIN ONC

[10]

JOSS R, 1982, SCHWEIZ MED WOCHENSC, V111, P1614

← 1 2 →